SCHEMBL24877853

SCHEMBL24877853

COC(=O)c1n[nH]c2c1CCC2

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 2/20 0.64
KMT2A Q03164 2/20 0.59
TSHR P16473 1/20 0.57
GAA P10253 2/20 0.54
RXFP1 Q9HBX9 1/20 0.54
NPC1 O15118 9/20 0.51
RAB9A P51151 7/20 0.51
SMN1; SMN2 Q16637 5/20 0.51
ALDH1A1 P00352 1/20 0.49
KDM4C Q9H3R0 1/20 0.46
MAPT P10636 6/20 0.45
PKM P14618 3/20 0.45
PAX8 Q06710 1/20 0.45
KLF5 Q13887 1/20 0.45
LMNA P02545 5/20 0.44
TP53 P04637 2/20 0.44
KDM4E B2RXH2 2/20 0.44
HTT P42858 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1007395 0.97 HCAR2 (0.64) HCAR2KMT2ATSHRGAARXFP1
SCHEMBL5079536 0.82 HCAR2 (0.58) HCAR2KMT2ATSHRGAARXFP1
SCHEMBL21764920 0.80 HCAR2 (0.70) HCAR2KMT2ATSHRGAARXFP1
SCHEMBL19005814 0.79 KDM4C (0.42) HCAR2KMT2ATSHRGAARXFP1
SCHEMBL5951775 0.79 KMT2A (0.58) HCAR2KMT2ATSHRGAARXFP1
SCHEMBL1663622 0.78 HCAR2 (1.00) HCAR2KMT2ATSHRGAARXFP1
SCHEMBL14487544 0.78 HCAR2 (0.65) HCAR2KMT2ATSHRGAARXFP1
SCHEMBL1149314 0.78 TSHR (0.59) HCAR2KMT2ATSHRGAARXFP1
SCHEMBL19366148 0.78 HCAR2 (0.47) HCAR2KMT2ATSHRGAARXFP1
Hydrochloric Acid SCHEMBL28380923 0.78 KDM4C (0.41) HCAR2KMT2ATSHRGAARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230008022-A1 NOVEL SUBSTITUTED PIPERAZINE AMIDE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS MERCK SHARP & DOHME CORP. (US) 2023-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230008022-A1 NOVEL SUBSTITUTED PIPERAZINE AMIDE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS IDO1, IDO2, KYNU HCAR2 247/4885KMT2A 520/4885TSHR 3557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.